Additional file 10: Figure S6. PU.1 depletion fails to block HDACi-induced gene expression changes in K562. (a) Boxplots of fold-change in RNA-seq expression for SAHA treatment of vector control-, shRNA 1-, or shRNA 2-transfected cells (n = 2 replicates) for genes that either increase or decrease significantly in vector control K562 (FDR < 0.05). (b) Heatmap of individual replicate expression values (FPKM values scaled across each row) for genes significantly differential following SAHA treatment in vector control K562. Note the distinction between all vehicle treated and all SAHA-treated samples and lack of distinction between PU.1 knockdown and vector control samples
Figure S5. Expression of HDAC1, HDAC2 and HDAC6 mRNA following treatment of UCCs with 19i or SAHA. E...
Figure S1. (A) Densitometry analysis of western blot shows efficacy of HDAC 1 and HDAC 2 knockdown a...
BACKGROUND: Small molecule inhibitors of histone deacetylases (HDACi) hold promise as anticancer age...
Additional file 8: Figure S5. PU.1 knockdown fails to block most HDACi-induced chromatin accessibili...
Additional file 7: Figure S4. PU.1 overexpression-driven chromatin accessibility changes are not lin...
Additional file 6: Figure S3. PU.1 and H3K4me1 immunoprecipitation. ChIP-qPCR for six DHS sites that...
Additional file 9: Table S4. Cuffdiff output for differentially expressed (RNA-seq) genes following ...
Additional file 5: Table S3. RNA-seq expression data for ETS family transcription factors detected i...
Additional file 6. Titration analysis of potential HDAC inhibitors. (A) Overview of different HDAC c...
Figure S6. Effect of 19i treatment on the expression of class IIA HDAC mRNAs in HDAC4 overexpressing...
A table showing âpattern specification process genesâ that are up-regulated by HDACi treatment
Human Epigenetic Chromatin Modification Enzymes and Epigenetic Chromatin Remodeling Factors RT2 Prof...
The global changes in histone modification and cell cycle profile in cells treated with HDACi
<p>(<b>A</b>) ChIP assay shows increased acetylation of histones H3 (left panel) and H4 (right panel...
<p>(<b>A</b>) Treatment of cells with <i>HDAC1</i> dsRNA results in increased transcript levels for ...
Figure S5. Expression of HDAC1, HDAC2 and HDAC6 mRNA following treatment of UCCs with 19i or SAHA. E...
Figure S1. (A) Densitometry analysis of western blot shows efficacy of HDAC 1 and HDAC 2 knockdown a...
BACKGROUND: Small molecule inhibitors of histone deacetylases (HDACi) hold promise as anticancer age...
Additional file 8: Figure S5. PU.1 knockdown fails to block most HDACi-induced chromatin accessibili...
Additional file 7: Figure S4. PU.1 overexpression-driven chromatin accessibility changes are not lin...
Additional file 6: Figure S3. PU.1 and H3K4me1 immunoprecipitation. ChIP-qPCR for six DHS sites that...
Additional file 9: Table S4. Cuffdiff output for differentially expressed (RNA-seq) genes following ...
Additional file 5: Table S3. RNA-seq expression data for ETS family transcription factors detected i...
Additional file 6. Titration analysis of potential HDAC inhibitors. (A) Overview of different HDAC c...
Figure S6. Effect of 19i treatment on the expression of class IIA HDAC mRNAs in HDAC4 overexpressing...
A table showing âpattern specification process genesâ that are up-regulated by HDACi treatment
Human Epigenetic Chromatin Modification Enzymes and Epigenetic Chromatin Remodeling Factors RT2 Prof...
The global changes in histone modification and cell cycle profile in cells treated with HDACi
<p>(<b>A</b>) ChIP assay shows increased acetylation of histones H3 (left panel) and H4 (right panel...
<p>(<b>A</b>) Treatment of cells with <i>HDAC1</i> dsRNA results in increased transcript levels for ...
Figure S5. Expression of HDAC1, HDAC2 and HDAC6 mRNA following treatment of UCCs with 19i or SAHA. E...
Figure S1. (A) Densitometry analysis of western blot shows efficacy of HDAC 1 and HDAC 2 knockdown a...
BACKGROUND: Small molecule inhibitors of histone deacetylases (HDACi) hold promise as anticancer age...